Tested Applications
| Positive WB detected in | A549 cells, human milk, mouse lung tissue, Jurkat cells, human placenta tissue |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:6000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15804-1-AP targets GLRX in WB, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag8535 Product name: Recombinant human GLRX protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-106 aa of BC005304 Sequence: MAQEFVNCKIQPGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLEFVDITATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLVSLQQSGELLTRLKQIGALQ Predict reactive species |
| Full Name | glutaredoxin (thioltransferase) |
| Calculated Molecular Weight | 106 aa, 12 kDa |
| Observed Molecular Weight | 12 kDa |
| GenBank Accession Number | BC005304 |
| Gene Symbol | GLRX |
| Gene ID (NCBI) | 2745 |
| RRID | AB_11232210 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P35754 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for GLRX antibody 15804-1-AP | Download protocol |
| WB protocol for GLRX antibody 15804-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
GLRX Polyclonal Antibody (15804-1-AP) has 18 publications. Citations appear in journals including Acta Pharmaceutica Sinica B, Advanced Science, Biomaterials, Journal of Pharmaceutical Analysis, Antioxidants, Free Radical Biology and Medicine, Biochemical Pharmacology, European Journal of Pharmacology, Scientific Reports, Biomedicines, Cell Research (Exp Cell Res), Neuroreport, Molecular Vision, and eLife. Research fields cover glutathionylation/oxidative stress, redox homeostasis, ferroptosis, diabetes and glucose metabolism, cardiac/ischemic injury, diabetic foot ulcer and cataracts, neurodegeneration, cancer hypoxia resistance, immune thrombocytopenia, and bone regeneration. Applications include WB, IF, and IP.
| Species | Application | Title |
|---|---|---|
Acta Pharm Sin B Dihydrotanshinone I preconditions myocardium against ischemic injury via PKM2 glutathionylation sensitive to ROS | ||
Adv Sci (Weinh) Targeting Cystine Metabolism in the Lung Cancer Environment Enhances the Efficacy of Immune Checkpoint Inhibition
| ||
Biomaterials Modeling calcific aortic valve disease with engineered human valve tissues identifies SAMHD1 as a therapeutic target. | ||
J Pharm Anal Naringenin boosts Parkin-mediated mitophagy via estrogen receptor alpha to maintain mitochondrial quality control and heal diabetic foot ulcer. | ||
J Pharm Anal Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites | ||
Antioxidants (Basel) Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2 |







